Jiangyuan Zhou
Member of Yi Ji's pediatric vascular-anomalies and surgical-oncology team; co-author on the sirolimus-for-Kaposiform-hemangioendothelioma study.
West China Hospital, Sichuan University · Pediatric surgical oncology & vascular anomalies
Jiangyuan Zhou is part of Yi Ji's Division of Oncology within Pediatric Surgery at West China Hospital — a high-volume center for pediatric vascular anomalies. The 2026 matched multicentre cohort study co-authored found that head-and-neck Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon responds strongly to sirolimus monotherapy.
The same name appears on dozens of other papers from Yi Ji's West China Hospital pediatric-surgery group, indicating an established, ongoing role on this clinical-research team.
Milestones in the Atlas
| Year | Evidence | Study |
|---|---|---|
| 2026 | H | High Responsiveness of Head and Neck Kaposiform Hemangioendothelioma Without Kasabach-Merritt Phenomenon to Sirolimus Monotherapy. XU2026 Co-author on the matched multicentre cohort study showing head-and-neck Kaposiform hemangioendothelioma (without Kasabach-Merritt phenomenon) responds strongly to sirolimus monotherapy. |
Co-authors in the Atlas
People with a profile here who share at least one study with Jiangyuan Zhou.
- Yulang Xu Paediatric surgeon-researcher who led a multicentre study showing that head-and-neck kaposiform hemangioendothelioma responds especially well to the mTOR inhibitor sirolimus